Clinical Trials
4 trialsNCT01164202 2022-03-18
SATURNE
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT00428220 2019-06-27
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
Pfizer
Phase NA Completed
NCT00361309 2014-03-18
SU011248 in Advanced Hepatocellular Carcinoma
Massachusetts General Hospital
Phase 2 Completed
NCT00514228 2012-06-26
Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Swiss Cancer Institute
Phase 2 Completed